Q1 EPS Estimates for agilon health Decreased by Analyst

agilon health, inc. (NYSE:AGL) – Research analysts at William Blair reduced their Q1 2025 earnings estimates for agilon health in a research note issued to investors on Tuesday, February 25th. William Blair analyst R. Daniels now forecasts that the company will earn $0.00 per share for the quarter, down from their previous forecast of $0.05. William Blair currently has a “Market Perform” rating on the stock. The consensus estimate for agilon health’s current full-year earnings is ($0.59) per share. William Blair also issued estimates for agilon health’s Q1 2026 earnings at $0.05 EPS, Q2 2026 earnings at ($0.02) EPS, Q3 2026 earnings at ($0.08) EPS and Q4 2026 earnings at ($0.13) EPS.

Several other research analysts have also recently weighed in on the stock. Needham & Company LLC reiterated a “hold” rating on shares of agilon health in a report on Wednesday. TD Cowen reduced their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a report on Monday, November 11th. JMP Securities cut shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Monday, November 11th. Royal Bank of Canada increased their target price on shares of agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a report on Wednesday. Finally, Stifel Nicolaus increased their target price on shares of agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a report on Wednesday. Two analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $3.95.

agilon health Stock Down 9.4 %

agilon health stock opened at $3.29 on Thursday. The stock has a market capitalization of $1.36 billion, a PE ratio of -3.50 and a beta of 0.66. agilon health has a twelve month low of $1.50 and a twelve month high of $7.73. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The company has a 50 day moving average of $2.91 and a 200-day moving average of $3.04.

Hedge Funds Weigh In On agilon health

Large investors have recently modified their holdings of the stock. Oak Thistle LLC bought a new position in shares of agilon health in the fourth quarter valued at about $25,000. Ieq Capital LLC acquired a new position in shares of agilon health in the fourth quarter valued at about $26,000. Signaturefd LLC grew its stake in shares of agilon health by 143.0% in the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock valued at $27,000 after acquiring an additional 8,467 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of agilon health in the third quarter valued at about $28,000. Finally, Humankind Investments LLC acquired a new position in shares of agilon health in the fourth quarter valued at about $30,000.

Insiders Place Their Bets

In related news, Director Karen Mcloughlin acquired 25,000 shares of the company’s stock in a transaction dated Friday, December 13th. The shares were bought at an average cost of $2.20 per share, with a total value of $55,000.00. Following the completion of the transaction, the director now directly owns 73,166 shares of the company’s stock, valued at $160,965.20. This trade represents a 51.90 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director John William Wulf acquired 45,000 shares of the company’s stock in a transaction dated Thursday, December 5th. The stock was bought at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the completion of the transaction, the director now directly owns 206,133 shares of the company’s stock, valued at approximately $449,369.94. This trade represents a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have bought 77,500 shares of company stock valued at $169,600. 3.20% of the stock is currently owned by corporate insiders.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.